Howard Y. Chang

Howard Y. Chang

Directeur Technique/Scientifique/R&D chez AMGEN INC.
Health Technology
Commercial Services
Consumer Services

Profil

Howard Y.
Chang
is the founder of Accent Therapeutics, Inc., founded in 2017.
Dr. Chang is also the founder of Epinomics, Inc.,Cartography Biosciences, Inc.,Orbital Therapeutics, Inc...
Dr. Chang currently holds the position of Chief Scientific Officer & SVP-Global Research at Amgen, Inc. since 2024.
Dr. Chang is a member of the National Academy of Sciences, the American Academy of Arts & Sciences, and the National Academy of Medicine (United States).
Dr. Chang completed undergraduate education at Harvard University, earned a doctorate from the Massachusetts Institute of Technology, and earned a doctorate from Harvard Medical School.

Postes actifs de Howard Y. Chang

SociétésPosteDébut
AMGEN INC. Directeur Technique/Scientifique/R&D 16/12/2024
Fondateur -
Fondateur -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Anciens postes connus de Howard Y. Chang

SociétésPosteFin
Fondateur -
Fondateur -
Voir l'expérience en détail de Howard Y. Chang

Formation de Howard Y. Chang

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

97

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Consumer Services

Finance

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Technology Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Howard Y. Chang
🔇